NRP1 and rheumatic disorder: These results are in line with findings from a conference abstract published in Annals of the Rheumatic Diseases [26], which reported that BDCA-2, BDCA-4, and CD123 markers are not exclusively pDC-specific and may also appear on CD14+ cells after 24 h in vitro culture in both healthy and SLE patients.